Speaker illustration

Doctor Karan Bami

St. Michael's Hospital, Toronto (Canada)

Effects of empagliflozin on cardiac function in patients with type 2 diabetes mellitus: echocardiographic substudy of the EMPA-HEART cardiolink-6 trial

Event: ESC Congress 2019

Topic: Systolic and Diastolic Function

Session: Echo cardiomyopathy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb